Heterozygous CDKN2A/B deletion has not been shown to have a definitive effect on grading of IDH-mutant astrocytomas [32], and has not been previously documented in the setting of a dual IDH1/2 mutation. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).